OX40 drives protective vaccinia virus-specific CD8 T cells.
about
Science gone translational: the OX40 agonist storyCD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.Control of immunity by the TNFR-related molecule OX40 (CD134)OX40 facilitates control of a persistent virus infection.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in miceA stimulating way to improve T cell responses to poxvirus-vectored vaccinesRegulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus.The significance of OX40 and OX40L to T-cell biology and immune disease.CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infectionPreferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-βPathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation.Activation of OX40 prolongs and exacerbates autoimmune experimental uveitisBasophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammationPD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity.Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cellsAn alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesExtent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.C-Myc regulation by costimulatory signals modulates the generation of CD8+ memory T cells during viral infection.The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesInherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.Transcription Factor Bcl11b Controls Effector and Memory CD8 T cell Fate Decision and Function during Poxvirus InfectionHigh frequencies of virus-specific CD8+ T-cell precursors.Tissue-specific programming of memory CD8 T cell subsets impacts protection against lethal respiratory virus infection.The role of OX40-mediated co-stimulation in T-cell activation and survival.Costimulation signals for memory CD8+ T cells during viral infections.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory virusesTumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.OX40, OX40L and Autoimmunity: a Comprehensive Review.Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.OX40 Cooperates with ICOS To Amplify Follicular Th Cell Development and Germinal Center Reactions during Infection.
P2860
Q27022436-04E08BD6-3CB2-4E05-BAFF-322BCCA3648DQ33677183-82AD3D1E-4090-44D2-91D3-25B4A38AC49DQ33899607-6A220CC2-8462-47CB-99C6-59B07D0339BEQ34411863-6AA8366B-48E7-4023-8B97-B6ECCAAF8319Q34428899-C9E7953C-615C-46A2-AECD-894AD4FC19A6Q34429078-7A282DCB-D988-413C-8F82-AA8F7C9F9C32Q34926132-F60DF937-DA74-48AD-AE7F-E3EB67C0CA16Q34950531-D16ABF75-A26F-4551-BDCF-259F93E53795Q34979946-53CB0D4C-57F1-4164-A0F9-060ABC92EFA9Q35035884-31470A21-0413-4B34-94CC-D20D4AC84148Q35193006-76812666-2F91-4F9D-BF41-E4202F9E588EQ35292546-9C4F222C-0AFF-4C18-A606-AD52C26AF358Q35523289-7E7656D4-5418-46D9-9AD6-40EB67111676Q35524673-583E3735-FFAE-40CF-A1E0-E92DC4025AFBQ35608058-50D2E7AE-0439-4833-B071-0B9D36005A06Q35611447-21F5D0A9-20DF-4189-BCA6-91B077C77991Q35627064-AA4794A5-B80C-4FF9-BB83-07DA9E416234Q35717963-781B9CDE-487C-4487-BDEC-F6ECF65494A3Q35876220-4C16EDF7-A27A-49D0-8DB5-C1985B5C0438Q35988486-829555FA-D7BA-4F26-B3FB-FDA491698957Q36382421-204D9433-360B-4949-A78B-2E7A5A441C6EQ36394928-1134DA96-6EBD-42EA-B1EB-93ED34A49C40Q36433932-4F357BF3-E356-4482-B692-EA776F2ED0B6Q36531690-46D34E48-AACF-490B-875C-6A62C411939EQ36823985-E5BFCC44-8406-492C-BF4C-2E3776C0C178Q36940326-BDE544C5-D6E4-469A-8EEB-5C6CC4CABE63Q37125732-5412C1A6-4EA0-485B-A6D1-A24BFF787CD6Q37265478-E8E7C606-939B-43FA-BB6F-A8F00A4E0E91Q37334885-77163AA3-E5B6-4CBC-B65F-19DE700FA84CQ37452503-AABB5965-1401-4C12-A4E2-4F557BB23390Q37500312-E0236E41-91E4-40EA-B1AF-009C1B7D3E81Q37524064-77F2A420-D95F-4ED8-B3DB-441EB5577B71Q37685171-99914C6D-7A86-4FFE-9047-9E9C21C35053Q37727208-1F16E4FE-B7B4-4B0C-8016-01A56D20F054Q37948126-1F3797F0-A357-4555-931F-F10AC2CC571BQ38217028-83065277-22D9-4C57-8EC1-049114D4AA22Q38555213-346A8D6F-8E73-4024-9D57-CDD9D22169B2Q38802594-415DA4DB-CA72-4E76-8D18-28021A8CDBCCQ40060920-3EBF80C6-7760-4AD5-A5B7-B9A9FE5A4CE8Q40432376-207C5F9C-CC7A-42B9-BFA1-D8DAA4F32093
P2860
OX40 drives protective vaccinia virus-specific CD8 T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
OX40 drives protective vaccinia virus-specific CD8 T cells.
@en
OX40 drives protective vaccinia virus-specific CD8 T cells.
@nl
type
label
OX40 drives protective vaccinia virus-specific CD8 T cells.
@en
OX40 drives protective vaccinia virus-specific CD8 T cells.
@nl
prefLabel
OX40 drives protective vaccinia virus-specific CD8 T cells.
@en
OX40 drives protective vaccinia virus-specific CD8 T cells.
@nl
P2093
P2860
P1476
OX40 drives protective vaccinia virus-specific CD8 T cells.
@en
P2093
Magdalini Moutaftsi
Michael Croft
Shahram Salek-Ardakani
Shane Crotty
P2860
P304
P356
10.4049/JIMMUNOL.181.11.7969
P407
P577
2008-12-01T00:00:00Z